Læknablaðið - 15.03.1995, Qupperneq 20

230
LÆKNABLAÐIÐ 1995; 81
12. Bjerkelund C, Oming OM. An evaluation of DC shock
treatment of atrialarrhythmias. Acta Med Scand 1968;
184: 481-91.
13. Morris JJ, Peter RH, Mclntosh HD. Electrical con-
version of atrial fibrillation. Ann Intern Med 1966; 65:
216-31.
14. Waris E, Kreus KE, Salokanenel J. Factors influencing
persistence of sinus rhythm after DC shock treatment of
atrial fibrillation. Acta Med Scand 1971; 189: 161-6.
15. Hillestad L, Bjerkelund C, Dale J, Maltau J. Storstein
O. Quinidine in the maintenance of sinus rhythm after
electroconversion of chronic atrial fibrillation. Br Heart
J 1971; 33: 518-21.
16. Sodermark T, Jonsson B, Olsson A, Orö L, Wallin H,
Edhag O, et al. Effect of quinidine in maintaining sinus
rhythm after conversion of atrial fibrillation and flutter.
Br Heart J 1975; 37: 486-92.
17. Van Gelder IC, Crijns H, Van Gilst WH, Verwer R, Lie
KL. Prediction of uneventful cardioversion and mainte-
nance of sinus rhythm from direct current electrial car-
dioversion of chronic atrial fibrillation and flutter. Am J
Cardiol 1991; 68: 41-6.
18. Lundström T, Ryden L. Chronic atrial fibrillation.
Long-term results of direct current cardioversion. Acta
Med Scand 1988; 223: 53-9.
19. Halpem SW, Ellrodt G, Singh BN, Mandel WJ. Effica-
cy of intravenous procainamide infusion in converting
atrial fibrillation to sinus rhythm. Relation to left atrial
size. Br Heart J 1980; 44: 589-95.
20. Ewy G, Ulfers L, Hager W, Rosenfeldt AR, Roeske
WR, Goldman S. Response of atrial fibrillation to ther-
apy: role of etiology and left atrial diameter. J Electro-
cardiol 1980; 13: 119-24.
21. Flugelman MY, Hasin Y, Katznelson N, Kriwisky M,
Shefer A, Gotsman MS. Restoration and maintenance
of sinus rhythm after mitral valve surgery for mitral
stenosis. Am J Cardiol 1984; 54: 617-9.
22. Höglund C, Rosenhamer G. Echocardiographic left
atrial dimension as a predictor of maintaining sinus
rhythm after cardioversion of atrial fibrillation. Acta
Med Scand 1985; 217: 411-5.
23. Brodsky MA, Allen BJ, Walker CJ, Casey TP, Luckett
CR, Henry WL. Amiodarone for the maintenance of
sinus rhythm after conversion of atrial fibrillation in the
setting of a dilated left atrium. Am J Cardiol 1987; 60:
572-5.
24. Alam M, Thorstrand C. Left ventricular function in
patients with atrial fibrillation before and after cardio-
version. Am J Cardiol 1992; 69: 694-6.
25. Vaziri SM, Larson MG, BenjaminEJ, Levy D. Echocar-
diographic predictors of nonrheumatic atrial fibrillation.
The Framingham heart study. Circulation 1994; 89: 724-
30.
26. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chal-
mers TC. Efficacy of quinidine therapy for maintenance
of sinus rhythm after cardioversion. Circulation 1990;
82: 1106-16.
27. The National Heart, Lung and Blood Institute Working
Group on Atrial Fibrillation. Atrial Fibrillation: Cur-
rent understanding and research imperatives. J Am Coll
Cardiol 1993; 22: 1830-4.
28. Reimold SC, Cantillon CO, Friedman PL, Antman EM.
Propafenone versus sotalol for suppression of recurrent
symptomatic atrial fibrillation. Am J Cardiol 1993; 71:
558-63.
29. Graboys TB, Podrid PJ, Lown B. Efficacy of amioda-
rone for refractory supraventricular tachyarrhythmias.
Am Heart J 1983; 106: 870-6.
30. Petersen P, Gottfredsen J, Boysen G, Andersen ED,
Andersen B. Placebo controlled, randomized trial of
warfarin and aspirin for prevention of thromboembolic
complications in chronic atrial fibrillation: The Copen-
hagen AFASAK Study. Lancet 1989; i: 175-9.
31. The Boston Area Anticoagulation Trial for Atrial Fibril-
lation Investigators: The effect of low dose warfarin on
the risk of stroke in patients with non-rheumatic atrial
fibrillation. N Engl J Med 1990; 323: 1505-11.
32. Connolly SJ, Laupacis A, Gent M, Roberts RS, Caims
JA, Joyner C. for the CAFA study coinvestigators. Can-
adian Atrial Fibrillation Angicoagulation (CAFA)
Study. J Am Coll Cardiol 1991; 18: .349-55.
33. Stroke Prevention in Atrial Fibrillation Investigators.
Stroke prevention in atrial fibrillation study: final re-
sults. Circulation 1991; 84: 527-39.
34. Ezekowitz MD, Bridgers SL, James KE, Carliner NH,
Colling CI, Gornick CC, et al. Warfarin in the preven-
tion of stroke associated with non-rheumatic atrial fíbril-
lation. N Engl J Med 1992; 327: 1406-12.
35. Stroke Prevention in Atrial Fibrillation Investigators.
Warfarin versus aspirin for prevention of thromboembo-
lism in atrial fibrillation. Stroke prevention in atrial fi-
brillation II study. Lancet 1994; 343: 687-91.
36. Klein HO, Kaplinsky E. Verapamil and digoxin: their
respective effects on atrial fibrillation, their interaction.
Am J Cardiol 1982; 50: 894-902.
37. Williamson BD, Man KC, Daood E, Niebauer M,
Strickberger AS, Morady F. Radiofrequency catheter
modification of atrioventricular conduction to control
the ventricular rate during atrial fibrillation. N Engl J
Med 1994; 331: 910-7.